EFFECT OF FOOD ON THE BIOAVAILABILITY OF LOW-DOSE METHOTREXATE IN PATIENTS WITH RHEUMATOID-ARTHRITIS

被引：100

作者：

OGUEY, D

KOLLIKER, F

GERBER, NJ

REICHEN, J

机构：

[1] UNIV BERN,DEPT CLIN PHARMACOL,MURTENSTR 35,CH-3010 BERN,SWITZERLAND

[2] UNIV BERN,DEPT RHEUMATOL,CH-3010 BERN,SWITZERLAND

来源：

ARTHRITIS AND RHEUMATISM | 1992年 / 35卷 / 06期

关键词：

D O I：

10.1002/art.1780350603

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective. To evaluate the influence of food on the bioavailability of an oral dose of methotrexate in patients with rheumatoid arthritis. Methods. Methotrexate (15 mg) was given intravenously and orally, with or without a meal, to 10 patients. Blood samples were drawn at specific intervals to evaluate drug levels. Results. Food reduced the peak concentration, from a mean of 0.71-mu-moles/liter to 0.49-mu-moles/liter (P < 0.02), and slightly increased the time to peak concentration, from a mean of 1.3 hours to 2.0 hours. Bioavailability was highly variable (range 28-94%) but was not affected by food intake. Conclusion. Bioavailability of oral methotrexate shows marked interindividual variation but is not affected by the presence of food.

引用

页码：611 / 614

页数：4

共 17 条

[1] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].

ARNETT, FC ;

EDWORTHY, SM ;

BLOCH, DA ;

MCSHANE, DJ ;

FRIES, JF ;

COOPER, NS ;

HEALEY, LA ;

KAPLAN, SR ;

LIANG, MH ;

LUTHRA, HS ;

MEDSGER, TA ;

MITCHELL, DM ;

NEUSTADT, DH ;

PINALS, RS ;

SCHALLER, JG ;

SHARP, JT ;

WILDER, RL ;

HUNDER, GG .

ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324

[2]

COHEN MH, 1976, CANCER, V38, P1556, DOI 10.1002/1097-0142(197610)38:4<1556::AID-CNCR2820380418>3.0.CO

[3]

2-8

[4] LOW-DOSE METHOTREXATE KINETICS IN ARTHRITIS [J].

EDELMAN, J ;

BIGGS, DF ;

JAMALI, F ;

RUSSELL, AS .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (03) :382-386

[5]

FREEMANNARROD M, 1975, CANCER, V36, P1619, DOI 10.1002/1097-0142(197511)36:5<1619::AID-CNCR2820360514>3.0.CO

[6]

2-G

[7]

Gibaldi M., 1982, PHARMACOKINETICS, Vsecond

[8]

HARVEY VJ, 1984, CANCER CHEMOTH PHARM, V13, P91

[9]

HENDERSON ES, 1965, CANCER RES, V25, P1018

[10] PHARMACOKINETICS OF LOW-DOSE METHOTREXATE IN RHEUMATOID-ARTHRITIS PATIENTS [J].

HERMAN, RA ;

VENGPEDERSEN, P ;

HOFFMAN, J ;

KOEHNKE, R ;

FURST, DE .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (02) :165-171

← 1 2 →